Qualcomms Stock Surge Signals Rising Investor Confidence in AIDriven Device Revolution HFCL Shares Jump to Record High on 135 Crore RailTel Order Stock Rallies Over 160 in Two Months Aluminum Prices Surge Amid Iran Conflict US Companies Face Rising Cost Pressures Geopolitical Tensions Rise Russia Vows Retaliation Amid Ukraine Conflict Escalation European Rightwing Populists Shifting Perceptions on China 4 Key Insights Bullish Options Strategy on Apple Stock Offers Limited Risk Opportunity PLX Q1 2026 Earnings Massive EPS Surprise Drives Stock Higher Addentax Group Corp ATXG Q1 2025 Earnings Net Loss Reported Amid Modest Stock Gain NetSol Technologies NTWK Q1 2026 Earnings Profitability Breakthrough Drives Positive Stock Movement RMNI Q1 2026 Earnings EPS Falls Short of Estimates Despite Positive Stock Reaction SPB Q1 2026 Earnings EPS Surpasses Estimates by 127 Stock Declines 14 Nkarta Inc NKTX Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline Highlander Silver Corp HSLV Pulls Back From Recent Highs Key Support Levels in Focus Expro Group Holdings XPRO Edges Higher Amid Modest Gains Key Levels in Focus Yorkville Acquisition Corp Unit MCGAU Holds Steady at 1029 A Static SPAC Unit Under Scrutiny Apex Treasury Corporation APXT Holds Steady at 1002 Key Support and Resistance Levels in Focus Prime Medicine PRME Surges Over 11 as Gene Editing Stock Finds Support Near 313 Micron Reaches 1 Trillion Market Cap on AIDriven Memory Demand Surge Verrica Pharmaceuticals Q1 2026 Earnings EPS Miss Amid PreRevenue Stage Stock Rises 271 Valmont Industries VMI Gains 145 as Stock Approaches Key Resistance FVCB Q1 2026 Earnings EPS Beats Estimates by Nearly 4 UGI Q1 2026 Earnings EPS Misses Estimates but Stock Gains on Operational Resilience KHC Q1 2026 Earnings EPS Surges Past Estimates Amid Cost Discipline ENIC Q4 2025 Earnings EPS Beat Exceeds Expectations Amid Mixed Revenue Disclosures OUST Q1 2026 Earnings EPS Beat Lifts Lidar Makers Stock Boise Cascade Q1 2026 Earnings EPS Surpasses Estimates by Over 18 CRIS Q1 2026 Earnings Significant EPS Miss as Biotech Advances Pipeline Without Revenue